Clinical Trial Update: Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the addition of panitumumab to chemoradiation in locally advanced head and neck squamous cell carcinoma has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Head and Neck Cancer, Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2014-08-05